Mascellani G, Liverani L, Bianchini P, Parma B, Torri G, Bisio A, Guerrini M, Casu B
Opocrin S.p.A. Research and Development Laboratories, Corlo di Formigine, Modena, Italy.
Biochem J. 1993 Dec 15;296 ( Pt 3)(Pt 3):639-48. doi: 10.1042/bj2960639.
Dermatan sulphate (DS) obtained from bovine and pig mucosa and pig skin, and charge-enriched fractions of a selected DS preparation, were characterized in terms of charge density, M(r) and disaccharide composition of chondroitin ABC lyase digests, and by 13C-n.m.r. spectroscopy. Besides the major IdoA-GalNAc4SO3 sequences, all DS preparations contain about 10% disulphated disaccharide sequences (mostly IdoA2SO3-GalNAc4SO3, with minor amounts of IdoA-GalNAc4,6SO3). DS fragments (prepared by radical-catalysed depolymerization of DS and retaining the internal structure of the parent polysaccharide) as well as Smith degraded fragments [SD-DS, obtained by controlled degradation of periodate-oxidized and borohydride-reduced DS (RO-DS)] with the general structure GalNAc4SO3(IdoA2SO3-GalNAc4SO3)n-R (where R is the remnant of a glycol-split uronic acid, and n = 2-3 and 3-4) were characterized by one- and two-dimensional 1H-n.m.r., 13C-n.m.r. and disaccharide composition analysis. In accordance with previous findings [Maimone and Tollefsen (1990) J. Biol. Chem. 265, 18263-18271], only fragments with n > or = 3 significantly enhance the heparin cofactor II-mediated inhibition of thrombin. In natural DS preparations and their fractions, this activity (as well as the antithrombotic activity in an animal model) appears to require IdoA2SO3-containing sequences. The heparin cofactor II activity of DS, RO-DS and SD-DS fragments decreases with decreasing M(r). However, RO-DS fragments are more active than DS fragments of similar M(r), probably because of the extra flexibility endowed by glycol-split IdoA residues.
对从牛和猪黏膜以及猪皮肤中获得的硫酸皮肤素(DS),以及一种选定的DS制剂的电荷富集级分,进行了电荷密度、相对分子质量(M(r))、软骨素ABC裂解酶消化产物的二糖组成表征,并通过碳-13核磁共振(13C-n.m.r.)光谱进行分析。除了主要的艾杜糖醛酸-4-O-硫酸-N-乙酰半乳糖胺(IdoA-GalNAc4SO3)序列外,所有DS制剂均含有约10%的双硫酸化二糖序列(主要是艾杜糖醛酸2-O-硫酸-4-O-硫酸-N-乙酰半乳糖胺(IdoA2SO3-GalNAc4SO3),还有少量的艾杜糖醛酸-4,6-O-二硫酸-N-乙酰半乳糖胺(IdoA-GalNAc4,6SO3))。DS片段(通过自由基催化的DS解聚制备并保留母体多糖的内部结构)以及史密斯降解片段[SD-DS,通过对高碘酸盐氧化和硼氢化钠还原的DS(RO-DS)进行可控降解获得],其一般结构为GalNAc4SO3(IdoA2SO3-GalNAc4SO3)n-R(其中R是二醇裂解糖醛酸的残余部分,n = 2 - 3和3 - 4),通过一维和二维氢核磁共振(1H-n.m.r.)、碳-13核磁共振(13C-n.m.r.)和二糖组成分析进行表征。与先前的研究结果[迈蒙内和托勒夫森(1990年)《生物化学杂志》265, 18263 - 18271]一致,只有n≥3的片段能显著增强肝素辅因子II介导的凝血酶抑制作用。在天然DS制剂及其级分中,这种活性(以及在动物模型中的抗血栓活性)似乎需要含有艾杜糖醛酸2-O-硫酸(IdoA2SO3)的序列。DS、RO-DS和SD-DS片段的肝素辅因子II活性随M(r)的降低而降低。然而,RO-DS片段比类似M(r)的DS片段更具活性,这可能是由于二醇裂解的艾杜糖醛酸残基赋予了额外的灵活性。